What Role Does Adenovirus Play In Liver Disease?
Published on: January 1, 2025
What Role Does Adenovirus Play In Liver Disease?
Article author photo

Aviksha Gajendra Premanandha

MSc. Food Systems and Management, <a href="https://www.cranfield.ac.uk/som" rel="nofollow">Cranfield University, United Kingdom</a>

Article reviewer photo

Jagadeeswari Vardha

MSc in Epidemiology of Infectious Diseases and Antimicrobial resistance, University of Glasgow

Introduction

What is adenovirus?

Adenoviruses are a family of double-stranded DNA viruses known to cause various human illnesses, ranging from respiratory infections to conjunctivitis and gastroenteritis. They are non-enveloped and highly contagious, spreading through respiratory droplets, faecal-oral transmission, or contact with contaminated surfaces. While adenovirus infections are prevalent among children, they can affect individuals of all ages.1

Importance of liver

The liver is a vital organ responsible for numerous crucial functions in the body, including metabolism, detoxification, synthesis of proteins, and storage of nutrients. It plays a central role in the digestion and processing of nutrients from food, as well as in the regulation of glucose and lipid metabolism. Additionally, the liver is a key component of the immune system, helping to fight infections and remove toxins from the bloodstream.2

Liver diseases overview

Liver diseases encompass a broad spectrum of conditions that affect the structure and function of the liver. These diseases can be caused by various factors, including viral infections (such as hepatitis viruses), alcohol consumption, metabolic disorders, autoimmune conditions, and genetic abnormalities. Common liver diseases include hepatitis (acute and chronic), cirrhosis, fatty liver disease, liver cancer, and liver failure. These conditions can have significant morbidity and mortality if left untreated, making the understanding and management of liver diseases a critical aspect of healthcare.3

Adenovirus: basics

How does adenovirus spread?

Adenoviruses primarily spread through respiratory droplets produced when an infected person coughs or sneezes. They can also spread through contact with contaminated surfaces or objects, as well as through faecal-oral transmission. Adenovirus infections are highly contagious and can occur year-round, with outbreaks often occurring in crowded settings such as schools, military barracks, and daycare centers.4

Common infections

Adenoviruses can cause a variety of infections, including:

  • Respiratory infections: such as the common cold, bronchitis, and pneumonia
  • Conjunctivitis: commonly known as pink eye, characterized by inflammation of the eye's outermost layer
  • Gastrointestinal infections: leading to symptoms like diarrhoea, vomiting, and abdominal pain
  • Other infections: such as urinary tract infections and viral meningitis5

Adenovirus and liver disease

How does adenovirus infects liver?

Adenovirus can infect the liver through various mechanisms. Upon entry into the body, adenoviruses may disseminate via the bloodstream, leading to their presence in the liver. Additionally, adenoviruses can directly target liver cells (hepatocytes) by binding to specific receptors on the cell surface, facilitating viral entry and replication within hepatocytes. Once inside the liver cells, adenoviruses can hijack the host cell machinery to produce viral proteins and replicate their genome, leading to liver cell damage and dysfunction.6

Types of liver diseases caused by adenovirus

Adenovirus infections can result in various liver diseases, including:

  • Acute hepatitis: characterised by inflammation of the liver, leading to symptoms such as jaundice, abdominal pain, nausea, and fatigue
  • Fulminant hepatitis: a severe form of acute hepatitis marked by rapid liver failure, which can be life-threatening
  • Chronic hepatitis: prolonged inflammation of the liver, which may lead to progressive liver damage, fibrosis, and cirrhosis over time7

How the liver is affected

Adenovirus-induced liver diseases primarily affect hepatocytes, the main functional cells of the liver. Viral replication within hepatocytes can lead to cell injury, inflammation, and hepatocellular necrosis, contributing to liver dysfunction. The host immune response triggered by adenovirus infection further exacerbates liver damage, with immune cells infiltrating the liver tissue, and releasing inflammatory mediators. In severe cases, adenovirus-induced liver diseases can progress to liver failure, necessitating intensive medical management or liver transplantation.

Clinical presentation

Symptoms

The clinical presentation of adenovirus-induced liver disease can vary depending on the severity of the infection.7 Common symptoms may include:

  • Jaundice (yellowing of the skin and eyes)
  • Abdominal pain or discomfort
  • Nausea and vomiting
  • Fatigue and weakness
  • Loss of appetite
  • Dark urine
  • Clay-colored stools
  • Fever (in some cases)

Diagnosis

Diagnosis of adenovirus-induced liver disease typically involves a combination of clinical evaluation, laboratory tests, and imaging studies. Laboratory tests may include liver function tests (e.g., serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin), which can indicate liver inflammation and dysfunction. Molecular diagnostic techniques, such as polymerase chain reaction (PCR), may be used to detect adenovirus DNA in blood or liver tissue samples. Imaging studies, such as ultrasound or computed tomography (CT) scans, may reveal liver abnormalities or complications such as hepatomegaly (enlargement of the liver) or liver abscesses.5

Treatment

There is no specific antiviral treatment for adenovirus infections, including those affecting the liver. Treatment is generally supportive and focuses on managing symptoms and preventing complications. This may include rest, adequate hydration, and pain relief medications for symptomatic relief. In severe cases, particularly those involving fulminant hepatitis or liver failure, intensive medical care in a hospital setting may be necessary. Liver transplantation may be considered in life-threatening cases of liver failure refractory to medical management.8

Prevention and control

Vaccination

Vaccination is an essential strategy for preventing adenovirus infections. While there is no specific vaccine available for all adenovirus serotypes, vaccines have been developed for certain high-risk populations, such as military recruits and individuals at increased risk of severe adenovirus infections. These vaccines, typically live attenuated vaccines, target specific adenovirus serotypes known to cause outbreaks in these populations. Vaccination helps stimulate the immune system to produce protective antibodies against adenovirus, reducing the risk of infection and transmission.9

Hygiene

Practising good hygiene habits is crucial for preventing adenovirus transmission. This includes:

  • Regular handwashing with soap and water, especially after using the restroom and before eating or preparing food
  • Avoiding close contact with individuals who are sick with respiratory or gastrointestinal symptoms
  • Covering the mouth and nose with a tissue or elbow when coughing or sneezing to prevent the spread of respiratory droplets
  • Disinfecting frequently touched surfaces and objects, such as doorknobs, countertops, and toys, to reduce the risk of contamination10

Public health measures

Public health measures play a vital role in controlling adenovirus outbreaks and reducing transmission within communities. These measures may include:

  • Surveillance and monitoring of adenovirus infections to detect outbreaks and trends in disease activity
  • Implementation of infection control measures in healthcare settings to prevent healthcare-associated adenovirus infections
  • Education and communication campaigns to raise awareness about adenovirus transmission and prevention strategies among the general public, healthcare professionals, and high-risk populations
  • Collaboration between public health authorities, healthcare providers, and community organizations to coordinate outbreak response efforts and implement targeted interventions as needed11.

Future directions

Ongoing research

Ongoing research on adenovirus infections and their implications for liver disease is focused on several key areas. These include:

  • Understanding viral pathogenesis: investigating the mechanisms by which adenoviruses infect liver cells, evade the immune response, and cause liver damage
  • Vaccine development: continuing efforts to develop safe and effective vaccines against adenovirus infections, including novel vaccine platforms and strategies to target multiple adenovirus serotypes
  • Antiviral therapies: exploring new antiviral agents and treatment approaches to inhibit adenovirus replication and improve clinical outcomes in patients with adenovirus-induced liver disease
  • Host-virus interactions: studying the host immune response to adenovirus infection and identifying host factors that contribute to susceptibility or resistance to severe disease12

New treatments

The development of novel treatments for adenovirus-induced liver disease is an active area of investigation. Potential therapeutic strategies include:

  • Antiviral drugs: testing of new antiviral compounds or repurposed drugs with activity against adenoviruses, such as nucleoside analogues, protease inhibitors, and viral polymerase inhibitors
  • Immunomodulatory therapies: evaluating the use of immunomodulatory agents to enhance the host immune response against adenovirus infection or to suppress excessive inflammation and immune-mediated liver injury
  • Gene therapy approaches: exploring the use of gene therapy techniques to deliver therapeutic genes or RNA interference molecules targeting essential viral genes to inhibit adenovirus replication and spread in liver cells13

Importance of early detection

Early detection of adenovirus-induced liver disease is crucial for timely intervention and management. Prompt diagnosis allows healthcare providers to initiate appropriate supportive care measures, monitor disease progression, and implement infection control measures to prevent transmission to others. Early detection also enables the identification of high-risk patients who may benefit from more intensive medical management, such as those with underlying liver disease or immunocompromised status.14

Summary

Adenoviruses, a diverse family of DNA viruses, are known culprits behind a range of human illnesses, including respiratory infections, conjunctivitis, and gastroenteritis. Their modes of transmission via respiratory droplets, faecal-oral routes, or contact with contaminated surfaces render them highly contagious. Meanwhile, the liver, a vital organ, orchestrates metabolic, detoxification, and immune functions. Liver diseases, stemming from various causes like viral infections, alcohol consumption, or genetic predispositions, present significant health risks if untreated.

Adenoviruses can assail the liver either through the bloodstream or by directly targeting liver cells, potentially sparking liver diseases like acute or chronic hepatitis. Symptoms typically encompass jaundice, abdominal discomfort, and fatigue. The diagnosis hinges on a battery of clinical evaluations, laboratory tests, and imaging studies. However, treatment mainly revolves around supportive care, given the absence of specific antiviral therapies. Prevention strategies pivot on vaccination, hygienic practices, and public health interventions to curb outbreaks.

Ongoing research delves into viral pathogenesis, vaccine innovation, and pioneering treatments for adenovirus-induced liver diseases. Timely detection assumes paramount importance, underlining the need for vigilant surveillance and prompt diagnostics to avert severe complications.

References

  1. Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014 Jul;27(3):441–62.
  2. Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol [Internet]. 2017 July [cited 2024 May 9];14(7):397–411. Available from: https://www.nature.com/articles/nrgastro.2017.38 
  3. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. Easl clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018 Jul;69(1):182–236.
  4. Lynch JP, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med. 2016 Aug;37(4):586–602.
  5. Gray GC, McCarthy T, Lebeck MG, Schnurr DP, Russell KL, Kajon AE, et al. Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin Infect Dis [Internet]. 2007 Nov 1 [cited 2024 May 9];45(9):1120–31. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2064001/ 
  6. Wingfield T, Dearden L, Calvert P, Osanlou O, Johnston B, Chawla A, et al. Adenovirus Type 7 causing severe lower respiratory tract infection in immunocompetent adults: a comparison of two contrasting cases from an intensive care unit in North West England. Clin Infect Pract [Internet]. 2019 Oct [cited 2024 May 9];2:100007. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919333/ 
  7. Calcedo R, Vandenberghe LH, Roy S, Somanathan S, Wang L, Wilson JM. Host immune responses to chronic adenovirus infections in human and nonhuman primates. J Virol [Internet]. 2009 Mar [cited 2024 May 9];83(6):2623–31. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648267/ 
  8. Afkhami S, Yao Y, Xing Z. Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens. Mol Ther Methods Clin Dev [Internet]. 2016 Apr 27 [cited 2024 May 9];3:16030. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847555/ 
  9. Kajon AE, Ison MG. Severe infections with human adenovirus 7d in 2 adults in family, illinois, usa, 2014. Emerg Infect Dis [Internet]. 2016 Apr [cited 2024 May 9];22(4):730–3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806933/ 
  10. Nwanegbo E, Vardas E, Gao W, Whittle H, Sun H, Rowe D, et al. Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of the gambia, south africa, and the united states. Clin Diagn Lab Immunol [Internet]. 2004 Mar [cited 2024 May 9];11(2):351–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC371218/
  11. Alonso-Padilla J, Papp T, Kaján GL, Benkő M, Havenga M, Lemckert A, et al. Development of novel adenoviral vectors to overcome challenges observed with hadv-5–based constructs. Mol Ther [Internet]. 2016 Feb [cited 2024 May 9];24(1):6–16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754553/  
  12. Stone D, Liu Y, Li ZY, Tuve S, Strauss R, Lieber A. Comparison of adenoviruses from species b, c, e, and f after intravenous delivery. Molecular Therapy [Internet]. 2007 Dec 1 [cited 2024 May 9];15(12):2146–53. Available from: https://www.sciencedirect.com/science/article/pii/S1525001616327307
  13. Singh S, Kumar R, Agrawal B. Adenoviral vector-based vaccines and gene therapies: current status and future prospects. In: Adenoviruses [Internet]. IntechOpen; 2018 [cited 2024 May 9]. Available from: https://www.intechopen.com/chapters/62883
  14. Kim E, Okada K, Beeler JA, Crim RL, Piedra PA, Gilbert BE, et al. Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model. J Virol [Internet]. 2014 May [cited 2024 May 9];88(9):5100–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993798/
Share

Aviksha Gajendra Premanandha

MSc. Food Systems and Management, Cranfield University, United Kingdom

With a strong academic foundation in food systems, management, life sciences and practical experience in clinical investigation, microbiological analysis and innovative project involvement, I bring a multidisciplinary skillset to research endeavours.

An accomplished graduate with expertise spanning food safety, quality management, agri-food business innovation, postharvest technology, and food diagnostics.

Committed to leveraging my knowledge to contribute to meaningful research centre on enhancing human, plant, animal and environmental wellbeing.

I have published in peer-reviewed journals, presented at conferences, and filed a patent demonstrating my research acumen. Additionally, I have received multiple awards and scholarships recognizing my academic excellence.

With laboratory skills, data analysis capabilities and a passion for mentorship, I am well equipped to tackle complex challenges through insightful research.

arrow-right